HS
LJPC

HighVista Strategies’s La Jolla Pharmaceutical Company LJPC Stock Holding History

HighVista Strategies’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-25,493
Closed -$102K – 143
2021
Q3 		$102K Buy
+25,493
New +$101K 0.07% 98

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KT
Kevin Tang $783 AUM 75.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HighVista Strategies's LJPC Position: Q4 2021 in Review

HighVista Strategies sold out of La Jolla Pharmaceutical Company (LJPC) in Q4 2021, closing a stake of 25,493 shares — an estimated $102K sold.

HighVista Strategies first reported a position in LJPC in Q3 2021 and held it in 1 quarter. The position peaked at $102K in Q3 2021. 44 funds tracked by Wall St. Rank hold LJPC as of Q4 2021.

  • HighVista Strategies reported no remaining La Jolla Pharmaceutical Company position as of Q4 2021 after selling out during the quarter.
  • HighVista Strategies sold 25,493 La Jolla Pharmaceutical Company shares in Q4 2021, an estimated $102K.
  • HighVista Strategies first reported a position in La Jolla Pharmaceutical Company in Q3 2021 and held it in 1 quarter.
  • HighVista Strategies's La Jolla Pharmaceutical Company position peaked at $102K in Q3 2021.
  • 44 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q4 2021.

Based on HighVista Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.